Case report of scleredema of Buschke with monoclonal gammopathy and type 2 diabetes mellitus
DOI:
https://doi.org/10.47456/rbps.v25i2.41037Keywords:
Adult-onset scleredema, Diabetes Mellitus, ParaproteinemiasAbstract
Introduction: Scleredema of Buschke (SB) is a rare condition characterized by thickening and hardening of the skin, primarily affecting the neck, shoulders, and upper back. It is associated with diabetes mellitus, monoclonal gammopathy, infections, and other factors. It can cause limited mobility and discomfort. Diagnosis can be challenging, with prognosis linked to early detection. Case reports: We report two cases of SB associated with monoclonal gammopathy and diabetes mellitus, highlighting its relationship with various etiologies. Conclusion: The reported cases were diagnosed with SB, with case 1 involving a patient with diabetes and monoclonal gammopathy, classified as subtype 2, and case 2 related to poorly controlled glucose levels in the context of type 2 diabetes, classified as subtype 3. Both cases are undergoing variable treatment, experiencing periods of improvement, stabilization, and exacerbation.
Downloads
References
Dantas DC, Oliveira VM, Oyafuso LK, Cuce LC, Zaniboni MC, Miot HA. Escleredema de Buschke associado ao diabetes melito tipo 2: relato de caso e revisão da literatura. An Bras Dermatol. 2015; 90(5 Supl 1):S219-22. doi: 10.1590/abd1806- 4841.20153449.
Gervini RL, Carvalho GA, Paschoal RS, Azulay DR. Esclere¬dema de Buschke: relato de dois casos. An Bras Dermatol. 2001; 76(3):307-13. doi: 10.1590/s0365-05962001000300009.
Moreno-Arias GA, Hernández-Núñez A, García-González FJ, Linares-Barrios M. Escleredema de Buschke asociado a diabetes mellitus. Estudio de cuatro casos. Med Cutan Iber Lat Am. 2010; 38(6):269-72.
Roh EY, Kim JE, Kim YC. Buschke sclerederma refrac¬tory to conventional treatment: response to UV-A1 pho¬totherapy. J Dermatolog Treat. 2018; 29(7):709-711. doi: 10.1080/09546634.2018.1445323.
National Center for Biotechnology Information (US). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; c2021. Buschke Scleredema. 2021 Feb 27 [cited 2023 Oct 6]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545159/
Tappeiner C, Hirsiger S, Tyndall A, et al. Successful Treatment of Poststreptococcal Scleredema Adultorum Buschke with Intra¬venous Immunoglobulins. Arch Dermatol. 2008; 144(11):1486- 1487. doi:10.1001/archderm.144.11.1486
Tran D, Nami N. Scleredema Diabeticorum: A Case Report and Review of Literature. J Investig Med High Impact Case Rep. 2019;7:2324709619837767. doi:10.1177/2324709619837767
Lemes LR. Scleredema of Buschke associated with diffi¬cult-to-control type 2 diabetes mellitus. An Bras Dermatol. 2015; 90(6):891-3. doi: 10.1590/abd1806-4841.20154162.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
